Senti Biosciences Holdings SNTI
NASDAQ SNTI
$0.32 +0.01 (+3.91%)
At close: Oct 1, 2026 · 4:00 PM EDT

Senti Biosciences Holdings (SNTI) Revenue (2021 - 2026)

Updated

Senti Biosciences Holdings' Revenue was $17,000 in Q2 2026.

Analysis

Senti Biosciences Holdings (SNTI) Revenue (2021 - 2026) Analysis & Trends

For FY2025, Revenue at Senti Biosciences Holdings came in at $22,000.

  • Revenue shows a four-year compound annual growth rate of -70.1% (FY2021 to FY2025).
  • In earlier years, Revenue was $2.56 million in FY2023 (-40.2%), $4.29 million in FY2022 (+55.2%) and $2.76 million in FY2021.
  • The Q2 2026 figure marks the highest quarterly Revenue in data going back to Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Senti Biosciences Holdings 9.65 Mn 9.65 Mn - 17,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17,000.00
Sep 30, 2023 338,000.00
Jun 30, 2023 937,000.00
Mar 31, 2023 1.29 Mn
Dec 31, 2022 59,000.00
Sep 30, 2022 1.77 Mn
Jun 30, 2022 1.36 Mn
Mar 31, 2022 1.10 Mn
Dec 31, 2021 793,000.00
Sep 30, 2021 1.10 Mn
Jun 30, 2021 793,000.00
API Access

Senti Biosciences Holdings Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=SNTI&period=max&api_key=YOUR_API_KEY